Distribution of HPV genotypes in 282 women with cervical lesions: Evidence for three categories of intraepithelial lesions based on morphology and HPV type

Modern Pathology

Volumn 20, Issue 2, 2007, Pages 167-174

  Zuna, Rosemary E ^a   Allen, Richard A ^a   Moore, William E ^b   Lu, You ^a   Mattu, Rubina ^a   Dunn, S Terence ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Cervical carcinogenesis; Cervical carcinoma; High grade squamous intraepithelial lesion; HPV genotyping; Human papillomavirus; Low grade squamous intraepithelial lesion

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CONSENSUS SEQUENCE; CONTROLLED STUDY; DEVICE; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; OPEN READING FRAME; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VIRUS CARCINOGENESIS; VIRUS DIAGNOSIS; VIRUS MORPHOLOGY; WART VIRUS;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 33947262613     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800723     Document Type: Article

References (30)

1. zur Hausen H. Human papilloma viruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977;78:1-3.
2. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol 1976;20:505-509.
3. Purola E, Savia E. Cytology of gynecologic condyloma acuminatum. Acta Cytol 1977;21:26-31.
4. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix. II. Cytologic, colposcopic and histopathologic study. Acta Cytol 1977;21:379-390.
5. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-964.
6. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
7. Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.
8. Muñoz N, Bosch FX, de Sanjosé S, et al, International Agency for Research on Cancer Multicenter Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
9. Cogliano V, Baan R, Straif K, et al, WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005;6:204.
10. Kiviat NB, Critchlow CW, Kurman RJ. Reassessment of the morphological continuum of cervical intraepithelial lesions: Does it reflect different stages in the progression to cervical carcinoma? In: Muñoz N, Bosch FX, Shah KV, Meheus A (eds). The Epidemiology of Cervical Cancer and Human Papillomavirus. International Agency for Research on Cancer: Lyon, 1992, pp 59-66.
11. Kiviat NB. Natural history of cervical neoplasia: overview and update. Am J Obstet Gynecol 1996;175:1099-1104.
12. Kurman R, Solomon DS. The Bethesda System for Reporting Cervical/vaginal Cytologic Diagnoses. Springer-Verlag: New York, 1993.
13. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119.
14. Zuna RE, Allen R, Moore WM, et al. Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Mod Pathol 2004;17:1314-1322 advance published online July 16, 2004; doi:10.1038/modpathol.3800223.
15. Lorincz A, Temple GF, Kurman RJ, et al. Oncogenic association of specific human papillomavirus types in cervical neoplasia. J Natl Cancer Inst 1987;79:671-677.
16. Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-337.
17. Patten SF. Diagnostic Cytology of the Uterine Cervix, 2nd edn. S Karger: Basel, 1978.
18. Richart R. The natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1967;10:748-784.
19. Scully RE, Bonfiglio TA, Kurman RJ (eds). Classification of Female Genital Tract Tumors, 2nd edn. Springer-Verlag: Berlin, 1994.
20. Gravitt PE, Peyton CL, Apple RJ, et al. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-3027.
21. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-361.
22. Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
23. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
24. Clifford GM, Smith JS, et al. Comparison of HPV type distribution in high grade lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-105.
25. Sadler L, Saftlas A, Wang W, et al. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004;291:2100-2106.
26. Samson SL, Bentley JR, Fahey TJ, et al. The effect of loop electrosurgical excision procedure on future pregnancy outcome. Obstet Gynecol 2005;105:325-332.
27. Confortini M, Biggeri A, Cariaggi MP, et al. Intralaboratory reproducibility in cervical cytology. Results of the application of a 100-slide set. Acta Cytol 1993;37:49-54.
28. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates form the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-1505.
29. Castle PE, Solomon D, Schiffman M, et al. Human papillomavirus type 16 infections and 2 year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 2005;97:1066-1071.
30. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10 year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072-1079.